United States

People: Veracyte Inc (VCYT.OQ)

VCYT.OQ on NASDAQ Stock Exchange Global Market

12:37pm EDT
Change (% chg)

$-0.02 (-0.20%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Hanna, John 

Mr. John W. Hanna is Chief Commercial Officer of the Company. As chief commercial officer, Mr. Hanna will oversee sales, marketing and managed care for Veracyte, continuing to report to Mr. Hall. Mr. Hanna joined Veracyte in 2011, most recently serving as vice president of marketing. During his tenure, he has helped define clear patient-centric value propositions for Veracyte's genomic tests, leading to broad physician adoption and health plan reimbursement. Prior to Veracyte, Mr. Hanna held management positions in business strategy and development at IBM and Humana.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --